Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Registration study of Henggu bone wound healing agent in orthopedic cases
ChiCTR2000034475Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Heng-Gu-Gu-Shang-Yu-He-Ji in knee osteoarthritis (OA), osteonecrosis of the hip, bone fracture (Fx) and 1 more (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: WOMAC and VAS. Started Jul 2020; status: recruiting.
02
Drugs
Heng-Gu-Gu-Shang-Yu-He-Ji
03
Conditions
knee osteoarthritis (OA)osteonecrosis of the hipbone fracture (Fx)Herniated Lumbar Disk
Beyond the preview
Go deeper on ChiCTR2000034475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034475.